Veterinary Medicines

Fevaxyn Quatrifel, Injeksjonsvæske, suspensjon, til katt

Authorised
  • Feline panleucopenia virus, strain CU4, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline rhinotracheitis virus, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
Download as PDF

Product identification

Medicine name:
Fevaxyn Quatrifel, Injeksjonsvæske, suspensjon, til katt
Active substance:
  • Feline panleucopenia virus, strain CU4, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Feline rhinotracheitis virus, Inactivated
  • Chlamydia felis, strain Cello, Inactivated
Target species:
  • Cat
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain CU4, Inactivated
    8.50
    relative potency
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain 255, Inactivated
    1.26
    relative potency
    /
    1.00
    millilitre(s)
  • Feline rhinotracheitis virus, Inactivated
    1.39
    relative potency
    /
    1.00
    millilitre(s)
  • Chlamydia felis, strain Cello, Inactivated
    1.69
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
  • Intramuscular use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • NOMA
Authorisation number:
  • 8127
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 30/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."